Why are drug prices so high? Investigating th...

As anxiety grows around what AI means for the future of work, technologist Vlad Tenev delivers a clear-eyed look at what happens when the majority of today's jobs disappear — and why it's not what you think. After Modupe shares how to balance healthy trepidation with our capacity ...  Show more

What do you get when you combine a major flood and near-bankruptcy? For Whole Foods cofounder John Mackey, the answer reshaped his business into a household name. He takes us back to the night his first store was destroyed, showing how shifting from a win-lose mindset to a "win-w ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.

Rebecca Robbi ...

Back in the 1990s, Dr. Raghunath Mashelkar was in his office in New Delhi when he came across a puzzling story in the newspaper. Some university scientists in the U.S. had apparently filed a patent for using turmeric to help heal wounds. Mashelkar was shocked, because he knew tha ...  Show more